{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T00:09:48Z","timestamp":1648944588444},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/brain\/awz006","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T07:09:38Z","timestamp":1547881778000},"page":"e9-e9","source":"Crossref","is-referenced-by-count":1,"title":["Reply: Janus kinase 1\/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis"],"prefix":"10.1093","volume":"142","author":[{"given":"Yves","family":"Allenbach","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM UMRS_974, Center of Research in Myology, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Bolko","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM UMRS_974, Center of Research in Myology, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9gol\u00e8ne","family":"Toquet","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Robert Debr\u00e9 Hospital, University Hospital, Reims, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM UMRS_974, Center of Research in Myology, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"},{"name":"Division of Rheumatology, Department of Medicine, Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM UMRS_974, Center of Research in Myology, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"key\n\t\t\t\t2019022703304449300_awz006-B1","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1093\/brain\/awy255","article-title":"A child with severe juvenile dermatomyositis treated with ruxolitinib","volume":"141","author":"Aeschlimann","year":"2018","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"76","author":"Aggarwal","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B3","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1093\/brain\/awy256","article-title":"Reply: a child with severe juvenile dermatomyositis treated with ruxolitinib","volume":"141","author":"Allenbach","year":"2018","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B4","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/art.38779","article-title":"Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis","volume":"66","author":"Cohen","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.39463","article-title":"Decernotinib: a next-generation Jakinib","volume":"68","author":"Gadina","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B6","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awy105","article-title":"JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis","volume":"141","author":"Ladislau","year":"2018","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B10","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz005","article-title":"Janus kinase 1\/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis","author":"Papadopoulou","year":"2019","journal-title":"Brain"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B7","article-title":"Study of tofacitinib in refractory dermatomyositis (STIR): an open label pilot study in refractory dermatomyositis [abstract]","author":"Paik","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","article-title":"Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis","volume":"150","author":"Valenzuela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"key\n\t\t\t\t2019022703304449300_awz006-B9","doi-asserted-by":"crossref","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PloS One"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/142\/3\/e9\/27986401\/awz006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T03:32:04Z","timestamp":1551238324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/142\/3\/e9\/5305679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,1]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awz006","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2019,2,1]]}}}